Prognos Health

Liquid biopsies are revolutionizing cancer care, enabling earlier detection, personalized treatment, and improved patient outcomes. This innovative technology provides pharmaceutical companies with unprecedented opportunities for timely and targeted outreach to healthcare providers. Learn how in our latest blog post from Todd Somsel! Read more here: https://bit.ly/4cBnZhQ #LiquidBiopsies #HealthcareInnovation #PersonalizedMedicine

We are excited to join Future Pharma this year as sponsors! We have an exciting new product that we will be launching at Future Pharma: Prognos Pinpoint HCP! Come join us, network and learn more! Click here: https://lnkd.in/e4w4dvv3 . #FuturePharma #rwd #hcp #prognospinpoint

In case you missed it.... catch Peter Pancione and Jennifer Ferrer at American Society of Clinical Oncology (ASCO) starting today! Or book a time to connect over coffee or during lunch with the team here: https://lnkd.in/e3Jsk7JB #ascoannualmeeting #rwd #oncology

Prognos Health team members Peter Pancione and Jennifer Ferrer will be representing Prognos Oncology at ASCO (#ASCO24) next week in Chicago! We're excited to connect with fellow oncology professionals and showcase our innovative solutions for supporting complex clinical populations, including our newly launched oncology offerings designed to more precisely target HCPs and improve patient outcomes. Are you attending ASCO? Let's connect! Drop a comment below or book at meeting time with the Prognos team: https://lnkd.in/eD3QB89B #oncology #asco #asco24 #complexpatients #PrognosHealth

Traditional data management methods hinders progress. Siloed data across providers and payers creates a fragmented view of patient journeys, hindering research and innovation. This is where data logistics steps in. Prognos Health recently partnered with Datavant and Valuate Health Consultancy to explore how data logistics can securely connect healthcare data across disparate systems and make data accessible and usable for research and innovation. Download the white paper here: https://bit.ly/3wj95xf #healthcare #datalogistics #datamanagement #innovation #research

If you missed our webinar with GeneDx and Pharming Group N.V. here's a quick clip where Heather McLaughlin highlights how when working with GeneDX, her team carefully specified the patient cohort to focus on the data most relevant to their research to provide the biggest impact. 🧬 It is important have the right data and the right partners to guide that journey. #GeneticsResearch #RWD #healthcareinnovation

Check out this recent interview with Datavant and our CMIO Jason Bhan, MD on how lab data accelerates commercial timelines and how it can identify more patients, and sooner, who need treatment - especially in rare disease and oncology. Read the full interview here: https://hubs.ly/Q02rT4vJ0 #rwd #labdata #healthcareinnovation

Did you miss our impactful webinar on rare diseases last week with GeneDx and Pharming? No worries! We've got you covered. In this session, Amanda Singleton, ScM, CGC, MPH from GeneDx sheds light on the challenges patients face in their rare disease journey. She also dives into GeneDx's mission to accelerate diagnoses and treatments. Heather McLaughlin, PhD, FACMG, NYCoQ, CGMB of Pharming Group N.V. then discusses how they leverage real-world data to make a tangible difference in patient lives. Tenured Prog Peter Pancione moderated digging deep into hugely important "why" of genome and exome testing. This webinar is a must-watch for anyone interested in rare diseases and improving patient outcomes. Click to watch now: https://bit.ly/3VJlYLi #rwd #raredisease #healthcareinnovation #betteroutcomes

Uncertain about data privacy when using real-world data (RWD) in pharma? Join us this Friday, April 5 at 11:00am ET / 8:00am PT for the next session of our webinar series: Data Privacy and Governance Considerations When Using RWD in Commercial Pharma featuring Donna Salerno of Myriad Genetics and Emily Johnson of McDonald Hopkins LLC moderated by Prognos Health Chief Privacy Officer Hilary Weckstein. This webinar tackles key questions: Genetic vs. De-identified Data: Privacy differences explained. Safeguarding Patient Privacy: Red flags & choosing trustworthy partners. De-identification Techniques: Protecting patient data during access. Register here for the live webinar and for on-demand: https://bit.ly/4at77ZG #rwd #datagovernance #genetics

Prog Christopher N. Hayes did an incredible job today at Reuters Events Pharma sharing how Prognos Health is able to produce more timely and better targeting of HCPs serving complex clinical populations. And on his birthday! Happy birthday Chris! 🎉🥳 #repharma #raredisease #oncology #rwd